Katherine Ann Rubino
Patent Attorney
Caldwell Intellectual Property Law
katie@caldwellip.com
May 6, 2019
CAFC Affirms Nonobviousness of Vitamin B12 and Folate Administration Prior to Chemotherapy By: Katie Rubino On April 26, 2019, the Court of Appeals for the […]
April 22, 2019
IPR Incomplete: PTAB Fails to Initiate Indefinite IPR Petition By: Katie Rubino Recently on March 6, 2019 the Patent Trial and Appeal Board (PTAB) issued […]
April 8, 2019
PTAB Enacts New Pilot Program on Motions to Amend During Post Grant Proceedings By: Katie Rubino Recently the Patent Trial and Appeal Board (PTAB) instituted […]
March 24, 2019
Lessons Learned on the Eve of the 10,000th Post Grant Petition Filed at the PTAB By: Katie Rubino Background In 2011, Congress and then President […]
March 17, 2019
CAFC Affirms IPR Dismissal for Lack of Standing and Mootness By: Katie Rubino On February 7th, 2019 the Court of Appeals for the Federal Circuit […]
March 3, 2019
CAFC Upholds Unpatentability of Diagnostic Method Claims By: Katie Rubino On February 6th, 2019 the U.S. Court of Appeals for the Federal Circuit (CAFC) in Athena […]
February 18, 2019
First Cannabis Patent to Survive IPR Challenge In Part By: Katie Rubino On January 3rd, 2019 the Patent Trial and Appeal Board (PTAB) issued a final […]
February 5, 2019
CAFC Rules USPTO Exceeded Its Authority Adjusting Patent Term By: Katie Rubino Recently on January 27th, 2019 the U.S. Court of Appeals for the Federal Circuit […]
January 27, 2019
Buyer Beware: Secret Sales May Result in Subsequent Patent Invalidity By: Katie Rubino Recently on January 22, 2019, the Supreme Court affirmed the Federal Circuit’s […]
January 18, 2019
Final Decision Reached in Initial Insulin IPR Proceeding By: Katie Rubino On December 12th, 2018 the U.S. Patent and Trademark Appeal Board (PTAB) […]